One of the largest series is the one published by Pastorello et al., where they collected a total of 95 patients with prostate cancer and 150 extraspinal bone lesions diagnosed by PSMA-PET/CT, achieving a local control of 89% at 3 years and with 5.3% intraosseous relapses. This evidence concerns the gene FOLH1 and Familial prostate cancer.